GGrantIndex
Sort

8,912 grants matching sars cov 2

Project 1

$754,491
Ali Hassan Ellebedy · Washington University · U19 · FY2024 · AI

Dissolved Phase Hyperpolarized Xenon-129 MRI: a novel biomarker to quantify pulmonary pathology in young healthy e-cigarette users

$754,391
Yun Michael Shim · University Of Virginia · R01 · FY2024 · DA

Tuberculosis Immunopathogenesis During Superinfection with SARS-CoV2

$754,096
Adel M Talaat · University Of Wisconsin-Madison · R01 · FY2023 · AI

Molecular Allergy

$753,852
Geoffrey Mueller · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES

LatiNET, a Multilevel Social Network Model to Examine and Address SARS-CoV-2 Misinformation in Low-Income Latinx Communities.

$753,712
Mariano Juan Kanamori Nishimura · University Of Miami School Of Medicine · R01 · FY2023 · MD

Biochemical and Structural Studies of Viral Proteases

$753,658
John Louis · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK

Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in blood

$753,352
Tony Y. Hu · Tulane University Of Louisiana · R01 · FY2023 · AI

Identifying mechanisms by which metformin regulates T cell responses in obesity

$753,296
Nancie Maciver · Univ Of North Carolina Chapel Hill · R01 · FY2025 · DK

HIV-1 membrane fusion and inhibition

$752,675
Bing Chen · Boston Children'S Hospital · R01 · FY2025 · AI

Optimizing a small molecule inhibitor of SARS-CoV-2 replication and associated cytokine storm

$752,485
Jeffrey S Glenn · Stanford University · R01 · FY2024 · AI

Point-of-care Nucleic Acid Amplification Test for pangenomic Hepatitis C diagnosis in outpatient clinics

$752,475
Jonathan D Posner · University Of Washington · R01 · FY2025 · AI

Inborn errors of immunity in patients with life-threatening COVID-19

$752,461
Jean-Laurent Casanova · Rockefeller University · R01 · FY2022 · AI

SpongeBot: genetically engineered cells to suppress SARS-CoV-2 and future viruses

$752,435
Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2021 · EB

Analysis of immunologic mechanisms in patients with chronic lung disease after acute COVID infection

$752,410
Homer L Twigg · Indiana University Indianapolis · R01 · FY2024 · HL

Mechanism and Inhibition of SARS-CoV-2 Entry

$752,346
Sean P. J. Whelan · Washington University · R01 · FY2025 · AI

Mechanism and Inhibition of SARS-CoV-2 Entry

$752,346
Sean P. J. Whelan · Washington University · R01 · FY2022 · AI

Mechanism and Inhibition of SARS-CoV-2 Entry

$752,346
Sean P. J. Whelan · Washington University · R01 · FY2024 · AI

Mechanism and Inhibition of SARS-CoV-2 Entry

$752,346
Sean P. J. Whelan · Washington University · R01 · FY2023 · AI

COVID-19 Mother Baby Outcomes (COMBO): brain-behavior functioning

$752,196
Dani Dumitriu · Columbia University Health Sciences · R01 · FY2022 · MH

Effect of obesity and diabetes in regulating pulmonary and extra-pulmonary anti-viral immune responses

$752,147
Kamal Mohan Khanna · New York University School Of Medicine · R01 · FY2025 · DK

Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic Discovery

$751,987
Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2021 · AI

Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans

$751,928
Ivan Zanoni · Boston Children'S Hospital · R01 · FY2022 · AI

Tuberculosis Immunopathogenesis During Superinfection with SARS-CoV2

$751,882
Adel M Talaat · University Of Wisconsin-Madison · R01 · FY2024 · AI

Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2

$751,777
Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2022 · HL

Cincinnati Children's Clinical Center for Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes

$751,761
Amy Sanghavi Shah · Cincinnati Childrens Hosp Med Ctr · U01 · FY2025 · DK